Asensus Surgical Inc (ASXC)
0.26
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.2593
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical Research and Development Expense (TTM): 34.98M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 34.98M |
| December 31, 2023 | 37.02M |
| September 30, 2023 | 36.93M |
| June 30, 2023 | 34.38M |
| March 31, 2023 | 32.65M |
| December 31, 2022 | 28.94M |
| September 30, 2022 | 27.00M |
| June 30, 2022 | 24.72M |
| March 31, 2022 | 21.56M |
| December 31, 2021 | 19.35M |
| September 30, 2021 | 16.53M |
| June 30, 2021 | 16.73M |
| March 31, 2021 | 16.90M |
| December 31, 2020 | 16.62M |
| September 30, 2020 | 17.50M |
| June 30, 2020 | 18.71M |
| March 31, 2020 | 20.75M |
| December 31, 2019 | 22.47M |
| September 30, 2019 | 24.27M |
| June 30, 2019 | 23.23M |
| March 31, 2019 | 22.21M |
| December 31, 2018 | 21.82M |
| September 30, 2018 | 20.56M |
| June 30, 2018 | 20.61M |
| March 31, 2018 | 20.40M |
| Date | Value |
|---|---|
| December 31, 2017 | 21.99M |
| September 30, 2017 | 24.33M |
| June 30, 2017 | 26.45M |
| March 31, 2017 | 27.74M |
| December 31, 2016 | 29.27M |
| September 30, 2016 | 30.32M |
| June 30, 2016 | 30.36M |
| March 31, 2016 | 30.57M |
| December 31, 2015 | 29.67M |
| September 30, 2015 | 27.10M |
| June 30, 2015 | 29.11M |
| March 31, 2015 | 30.42M |
| December 31, 2014 | 27.94M |
| September 30, 2014 | 26.80M |
| June 30, 2014 | 20.65M |
| March 31, 2014 | 14.93M |
| December 31, 2013 | 12.70M |
| September 30, 2013 | 9.586M |
| June 30, 2013 | 7.905M |
| March 31, 2013 | 6.509M |
| December 31, 2012 | 4.905M |
| September 30, 2012 | 4.061M |
| June 30, 2012 | 3.808M |
| March 31, 2012 | 3.888M |
| December 31, 2011 | 3.367M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
16.53M
Minimum
Sep 2021
37.02M
Maximum
Dec 2023
24.56M
Average
22.85M
Median
Research and Development Expense (TTM) Benchmarks
| Glaukos Corp | 134.32M |
| Perspective Therapeutics Inc | 24.91M |
| Retractable Technologies Inc | 0.5812M |
| Xtant Medical Holdings Inc | 1.689M |
| Catheter Precision Inc | 0.272M |